{"id":"https://openalex.org/G6161576830","display_name":"ENSAYO CL\u00cdNICO FASE I-II MULTIC\u00c9NTRICO PARA EVALUAR SEGURIDAD Y EFICACIA DE UN MEDICAMENTO DE TERAPIA AVANZADA BASADO EN UNA C\u00d3RNEA ARTIFICIAL DE P\u00c9PTIDOS SIMILARES AL COL\u00c1GENO CON C\u00c9LULAS EPITELIALES PARA EL TRATAMIENTO DE ENFERMEDADES CORNEALES SEVERAS","description":"Las enfermedades corneales son una de las principales causas de ceguera en el mundo siendo el trasplante de c\u00f3rnea el tratamiento m\u00e1s utilizado. A pesar de ello, existe un n\u00famero indeterminado de pacientes con patolog\u00eda corneal severa que asocian alto riesgo de rechazo del injerto por insuficiencia limbar, da\u00f1o estromal y neovascularizaci\u00f3n corneal, no existiendo actualmente una alternativa terap\u00e9utica eficaz para ellos. Para estos casos, la ingenier\u00eda tisular surge con la ambici\u00f3n de generar c\u00f3rneas artificiales que conduzcan a una regeneraci\u00f3n \u00f3ptima de la c\u00f3rnea. En relaci\u00f3n con ello, s\u00f3lo dos productos producidos en el laboratorio han llegado a evaluarse a nivel cl\u00ednico como sustitutos del estroma corneal en pacientes con enfermedades corneales graves: sustitutos de fibrina-agarosa y sustitutos de col\u00e1geno humano recombinante. Las macromol\u00e9culas naturales como el col\u00e1geno o la fibrina son grandes, dif\u00edciles de procesar, heterog\u00e9neas y dependen de la fuente, haciendo la escalabilidad del producto casi imposible. Si bien el uso de col\u00e1geno humano producido de forma recombinante elimina la heterogeneidad, son todav\u00eda macromol\u00e9culas grandes que requieren un procesamiento significativo. Esto hace que los an\u00e1logos de p\u00e9ptidos cortos que se sintetizan f\u00e1cilmente, y que adem\u00e1s permiten la personalizaci\u00f3n y un escalado sencillo, emerjan como una alternativa realmente atractiva. Varios estudios in vitro e in vivo realizados por nuestra colaboradora May Griffith han demostrado que p\u00e9ptidos similares al col\u00e1geno conjugados con polietilenglicol y MPC fueron funcionalmente equivalentes a los implantes basados en col\u00e1geno recombinante. Con este perfil de seguridad y eficacia a nivel precl\u00ednico, proponemos realizar un ensayo cl\u00ednico multic\u00e9ntrico fase I-II en 20 pacientes con enfermedades corneales severas que asocien insuficiencia limbar y da\u00f1o estromal, seguidos durante 2 a\u00f1os, para evaluar la seguridad y eficacia de estos sustitutos corneales una vez implantados.","funder_award_id":"ICI19/00006","funder":{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","doi":"https://doi.org/10.13039/501100004587"},"funded_outputs":["https://openalex.org/W3157532970","https://openalex.org/W3160674833","https://openalex.org/W4285733205","https://openalex.org/W4392359454","https://openalex.org/W4410202898"],"funded_outputs_count":5,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":573650.0,"currency":"EUR","amount_usd":644438.41,"amount_usd_basis":"daily_rate","recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"grant","funder_scheme":null,"start_date":"2020-01-01","end_date":"2023-12-31","start_year":2020,"end_year":2023,"landing_page_url":"https://portalfis.isciii.es/proyecto?idProyecto=ICI19/00006","doi":null,"provenance":"portal_fis_isciii","lead_investigator":{"given_name":"Miguel","family_name":"Gonzalez Andrades","orcid":null,"role_start":null,"affiliation":{"name":"FUNDACION INVESTIGACION BIOMEDICA DE CORDOBA (FIBICO)","country":"ES","ids":null},"author":null,"institutions":null},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G6161576830","primary_topic":{"id":"https://openalex.org/T11828","display_name":"Corneal Surgery and Treatments","score":0.9917,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11828","display_name":"Corneal Surgery and Treatments","score":0.9917,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12264","display_name":"Tissue Engineering and Regenerative Medicine","score":0.0031,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10563","display_name":"Corneal surgery and disorders","score":0.0012,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/artificial-cornea","display_name":"artificial cornea","score":0.868},{"id":"https://openalex.org/keywords/corneal-disease","display_name":"corneal disease","score":0.639},{"id":"https://openalex.org/keywords/collagen-like-peptides","display_name":"collagen-like peptides","score":0.665},{"id":"https://openalex.org/keywords/peptide-hydrogels","display_name":"peptide hydrogels","score":0.512},{"id":"https://openalex.org/keywords/corneal-epithelial-cells","display_name":"corneal epithelial cells","score":0.817},{"id":"https://openalex.org/keywords/corneal-regeneration","display_name":"corneal regeneration","score":0.659},{"id":"https://openalex.org/keywords/corneal-transplantation","display_name":"corneal transplantation","score":0.573},{"id":"https://openalex.org/keywords/limbal-stem-cell-deficiency","display_name":"limbal stem cell deficiency","score":0.811},{"id":"https://openalex.org/keywords/corneal-neovascularization","display_name":"corneal neovascularization","score":0.926},{"id":"https://openalex.org/keywords/tissue-engineering","display_name":"tissue engineering","score":0.589},{"id":"https://openalex.org/keywords/advanced-therapy-medicinal-products","display_name":"advanced therapy medicinal products","score":0.552},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.307},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.646}],"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537,"id":"https://metadata.un.org/sdg/3"}],"institution_awarded":[],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-07-13T04:51:35.000Z"}
